Digital health start-up Healthi raises $3.1mn
Four-year-old digital health start-up Healthi has recently raised $3.1mn. Led by Montane Ventures, the funds will see the company further develop its technologies and build applications to fully drive patient engagement.
Focused on preventative healthcare, the company’s efforts to deliver personalised health prevention packages has seen it cater towards obesity, heart disease, diabetes prevention and much more.
“As spending in the sector increases, prevention will play an increasing role where AI and digital leveraged effectively, can enable that change [from curative to preventive healthcare],” commented Josh Bornstein, partner at Montane Ventures.
Utilising sophisticated data and analytics has made the company a strong choice for businesses to partner with, as well as insurance and healthcare companies. Its growth has also seen it expand to over 150 Indian cities.
- DiaMonTech and the development of non-invasive blood glucose monitoring
- 3D printing is no longer the technology of the future – it’s now here to stay
- Al Mazaya Holding completes its new medical centre in Kuwait
“This funding round gives us the confidence and resources to power forward in our mission to empower millions of users to live fuller lives by taking control of their health. The feedback and increasing traction that we have seen to date reinforce our vision that a strong focus on user experience and the right combination of technology and analytics can effectively help users to lead healthy lives,” explained Rekuram Varadharaj and Krishna Ulagaratchagan, founders of Healthi.
“The funds will be used to boot up applications that empower users to understand, engage with and take control of their health and to scale up the go-to-market efforts for the first application that is seeing increasing traction, namely driving engaging health benefits programs for corporate employees and family members,” they added.
Its impressive growth will see the number of users across India rapidly increase, where the company also aims to undertake a number of international pilots.
“The burden of non-communicable disease is on the rise, making preventive health extremely important. Historically, the focus of healthcare in India has mostly been curative in nature. As spending in the sector increases, prevention will play an increasing role where AI and digital leveraged effectively, can enable that change,” noted Josh Bornstein, partner at Montane Ventures.
“Healthi is a game changer. They have developed an innovative digital health platform with significant IP around predictive analytics and personalized engagement, that has applicability in many realms going forward, as already demonstrated by the traction that they have witnessed.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”